140 related articles for article (PubMed ID: 38555112)
1. Difficulties of gender affirming treatment in trans women with BRCA1+ mutation: A case report.
Piñar-Gutiérrez A; Dueñas Disotuar S; de Lara-Rodríguez I; Amuedo-Domínguez S; González-Cejudo C; Tejero-Delgado J; Mangas-Cruz MÁ
Endocrinol Diabetes Nutr (Engl Ed); 2024 Mar; 71(3):144-148. PubMed ID: 38555112
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
[TBL] [Abstract][Full Text] [Related]
3. Hormonal and surgical treatment in trans-women with BRCA1 mutations: a controversial topic.
Colebunders B; T'Sjoen G; Weyers S; Monstrey S
J Sex Med; 2014 Oct; 11(10):2496-9. PubMed ID: 25042481
[TBL] [Abstract][Full Text] [Related]
4. Complex Medical Decision-Making for a Trans-Feminine Youth with a BRCA1 Mutation.
Wolf-Gould CS; Riley MR; Carswell JM
LGBT Health; 2018; 5(4):221-225. PubMed ID: 29870317
[TBL] [Abstract][Full Text] [Related]
5. Gender identity: Current concepts and gender-affirming hormone therapy.
Pérez López G
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():27-37. PubMed ID: 36543601
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
7. A REVIEW OF BREAST DEVELOPMENT IN CISGENDER WOMEN AND IMPLICATIONS FOR TRANSGENDER WOMEN.
Reisman T; Goldstein Z; Safer JD
Endocr Pract; 2019 Dec; 25(12):1338-1345. PubMed ID: 31412232
[No Abstract] [Full Text] [Related]
8. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
[TBL] [Abstract][Full Text] [Related]
9. Endocrinology of Transgender Medicine.
T'Sjoen G; Arcelus J; Gooren L; Klink DT; Tangpricha V
Endocr Rev; 2019 Feb; 40(1):97-117. PubMed ID: 30307546
[TBL] [Abstract][Full Text] [Related]
10. Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study.
de Blok CJ; Dijkman BA; Wiepjes CM; Konings IR; Dreijerink KM; Barbé E; den Heijer M
Breast; 2021 Jun; 57():118-122. PubMed ID: 33831630
[TBL] [Abstract][Full Text] [Related]
11. Trans-counseling: A case series of transgender individuals at high risk for BRCA1 pathogenic variants.
Sacca RE; Koeller DR; Rana HQ; Garber JE; Morganstern DE
J Genet Couns; 2019 Jun; 28(3):708-716. PubMed ID: 30680866
[TBL] [Abstract][Full Text] [Related]
12. [Hormone treatment of transgender people: Long-term health effects and safety].
de Blok CJM; Wiepjes CM; Nota NM; den Heijer M
Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32757514
[TBL] [Abstract][Full Text] [Related]
13. Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.
Defreyne J; Van de Bruaene LDL; Rietzschel E; Van Schuylenbergh J; T'Sjoen GGR
Clin Chem; 2019 Jan; 65(1):119-134. PubMed ID: 30602477
[TBL] [Abstract][Full Text] [Related]
14. Masculinizing hormone therapy effect on breast tissue: Changes in estrogen and androgen receptors in transgender female-to-male mastectomies.
Chaum M; Grossi S; Chen J; Hu V; Ray E; Giuliano A; Bose S
Breast; 2023 Dec; 72():103596. PubMed ID: 37951051
[TBL] [Abstract][Full Text] [Related]
15. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
16. Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.
Patel H; Arruarana V; Yao L; Cui X; Ray E
Endocrine; 2020 Apr; 68(1):6-15. PubMed ID: 32067157
[TBL] [Abstract][Full Text] [Related]
17. Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults.
Sutherland N; Espinel W; Grotzke M; Colonna S
J Genet Couns; 2020 Aug; 29(4):625-633. PubMed ID: 32304336
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen and anti-androgen therapy for transgender women.
Tangpricha V; den Heijer M
Lancet Diabetes Endocrinol; 2017 Apr; 5(4):291-300. PubMed ID: 27916515
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Sexual Dysfunctions in Transgender Persons: Results from the ENIGI Follow-Up Study.
Kerckhof ME; Kreukels BPC; Nieder TO; Becker-Hébly I; van de Grift TC; Staphorsius AS; Köhler A; Heylens G; Elaut E
J Sex Med; 2019 Dec; 16(12):2018-2029. PubMed ID: 31668732
[TBL] [Abstract][Full Text] [Related]
20. [Nutritional problems in cis and trans women].
Castellanos-López I; González-Rodríguez LG; Bermejo LM; Cuadrado-Soto E; López-Sobaler AM
Nutr Hosp; 2023 Nov; 40(Spec No2):33-36. PubMed ID: 37929906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
